Search company, investor...
FlexGen company logo


Founded Year



Unattributed VC | Alive

About FlexGen

FlexGen is working towards the commercialization of a fast and flexible custom microarray synthesis instrument for genomic selection in sequencing and other applications.

Headquarters Location

Wassenaarseweg 72



Missing: FlexGen's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: FlexGen's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest FlexGen News

FlexGen Selects Orennia for Analytics and Insights That Support Its Growth in the US Storage Market

Nov 15, 2022

Download November 15, 2022 09:00 AM Eastern Standard Time CALGARY, Alberta--( BUSINESS WIRE )--Orennia Inc. (Orennia), a leading technology platform that provides data, analytics and insights to key players in the energy transition sector, announces one of its newest partnerships with cutting-edge energy storage integrator FlexGen. FlexGen and Orennia were first connected from an industry-leading research report that Orennia published highlighting top-performing battery storage assets. FlexGen will deploy Orennia’s proprietary analytics to improve its market intelligence on developer strategies, allowing its clients to perform better in the complex and rapidly changing battery storage market. FlexGen’s strategy, which focuses on bringing the most robust controls and energy storage capabilities to power markets across the US, aligns with Orennia’s mission to accelerate the energy transition by helping our clients increase investment returns. Orennia provides an all-in-one platform to help sophisticated investors in the energy transition, renewables and decarbonization sectors uncover and execute on the best investment opportunities. Orennia continues to expand its market presence among asset owners, operators, project developers, and capital providers - giving them capability to outcompete their peers. “We are excited to be working with such a forward-thinking and innovative company like FlexGen,” said Brook Papau, chief executive officer of Orennia. “Our platform is designed to help companies identify unique insights to make more efficient capital allocation decisions. We are looking forward to supporting FlexGen as they continue to grow their strong market position.” “Partnering with Orennia and having access to their analytics in the battery storage market across the US provides the FlexGen team with the unique insights we need as we ramp up our go-to-market strategy,” said Yann Brandt, chief commercial officer of FlexGen. “Leveraging their platform and seeing performance across existing energy storage assets highlights the track record that FlexGen has and increases our competitive advantage in the battery storage space.” About Orennia Inc. Orennia provides trusted commercial analytics to help inform investment and capital allocation decisions for energy transition spaces. Orennia’s insights, curated by highly experienced industry experts, help capital allocators in power and renewable, decarbonization and energy transition sectors make confident investment decisions and accelerate their time-to-value. To learn more, visit . About FlexGen Based in Durham, N.C., FlexGen is a leading integration services and software technology provider for energy storage solutions in the United States and globally. FlexGen designs and integrates storage solutions and the software platform that is enabling today’s energy transition. Leveraging its best-in-class energy management software and power electronics, FlexGen delivers utility-scale storage projects integrated with traditional and renewable power generation globally. Our clients and partners include the most technically and commercially demanding developers, utilities, cooperatives, government agencies and industrial companies in the world. To learn more, please visit . Contacts

FlexGen Frequently Asked Questions (FAQ)

  • When was FlexGen founded?

    FlexGen was founded in 2004.

  • What is FlexGen's latest funding round?

    FlexGen's latest funding round is Unattributed VC.

  • Who are the investors of FlexGen?

    Investors of FlexGen include Omnes Capital and BioGeneration Ventures.

  • Who are FlexGen's competitors?

    Competitors of FlexGen include Pepscan, BioGX, Arbovax, Complete Genomics, Helicos BioSciences and 11 more.

Compare FlexGen to Competitors

Signature Genomic Laboratories

Signature Genomic Laboratories aims to use microarray technology to help diagnose chromosome abnormal disabilities in children with developmental disabilities


Employing recent advances in sequencing, ASPE bead array, microarray technology, Q'Array is poised to provide a range of DNA testing, including genetic, chromosomal, biochemical, pharmacogenomics, paternity, and forensic identity testing.


Genepep company is focusing on peptides:discovery and synthesis of new endogenous peptides from natural sources, custom peptides synthesis, peptides sequencing, antibodies.


Chalex Corporation's precision-made chambered McMaster counting slides are used by researchers, laboratories, nematologists and veterinary practitioners throughout the world. Made of clear durable acrylic for long-lasting use, the company's slides also feature exact volumes thanks to injection-molded accuracy which yield consistent test results compared to other slides with handmade chamber spacers. The quality of these slides make them the standard the world over.

Nabsys Logo

Nabsys develops an electronic mapping solution for the analysis of genomic structural information. It offers solutions for genome assembly, structural variation, strain identification, and sample preparation. The company was founded in 2005 and is based in Providence, Rhode Island.

Cell Constructs .

KPS Technologies produces cyanine dyes that absorb and fluoresce at near- infrared wavelengths.  These molecules are useful as detection units since virtually all organic materials including biological tissues are penetrated by NIR radiation.  Potential applications are quite varied but those of interest are diagnostic ones including protein labeling, immunoassays and DNA sequencing.  The major market for these compounds will be instrument manufacturers. Custom made kits are available upon request.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.